Learn More
Cayman Chemical R4AmIno3hydroxybutyrIc 50mg

Supplier: Cayman Chemical 3153250 MG

A PPAR agonist 750- and 2500-fold selective for PPAR over PPARa and PPARY reduces increases in fasting blood glucose and serum insulin levels and decreases insulin resistance in Alms1 mutant (foz/foz) mice fed an atherogenic diet as a model of diet-induced obesity type 2 diabetes and NASH at 10 mg/kg per day for eight weeks decreases serum ALT as well as serum and hepatic cholesterol and triglyceride levels and reduces markers of NASH in the same model
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.